Analysis
| Earnings estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of analysts | 2 | 2 | 34 | 34 |
| Average estimate | 26.21 | 27.89 | 102.69 | 116.55 |
| Low estimate | 25.81 | 27.87 | 98.59 | 110.99 |
| High estimate | 26.60 | 27.90 | 107.40 | 126.70 |
| Last year EPS | 22.07 | 24.15 | 91.22 | 102.69 |
| Revenue estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 3 | 3 | 31 | 33 |
| Avg. estimate | 50.08B | 49.41B | 195.45B | 213.97B |
| Low estimate | 48.11B | 48.11B | 192.38B | 209.30B |
| High estimate | 51.47B | 50.35B | 198.68B | 220.57B |
| Last year sales | 46.68B | 45.93B | 179.43B | 195.45B |
| Sales growth | 0.07 | 0.08 | 0.09 | 0.09 |
| EPS trend |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 26.21 | 27.89 | 102.69 | 116.55 |
| 7 days ago | 26.02 | 26.78 | 103.68 | 117.54 |
| 30 days ago | 26.02 | 26.78 | 103.65 | 117.52 |
| 60 days ago | 25.76 | 26.17 | 103.84 | 117.70 |
| 90 days ago | 26.28 | 27.38 | 102.20 | 114.19 |
| EPS revisions |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 0 | 1 | 4 | 4 |
| Up last 30 days | 0 | 1 | 5 | 4 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 1 | 0 | 19 | 20 |